Tighiouart, Mourad |
Cedars-Sinai Medical Center
United States |
Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials |
3U01CA232859-05S1 |
|
Rachel Altshuler, Ph.D. |
Tollefsbol, Trygve O |
University Of Alabama At Birmingham
United States |
Combinatorial epigenetic-based prevention of breast cancer |
5R01CA178441-09 |
|
Gabriela Riscuta, M.D., CNS |
Toriola, Adetunji T |
Washington University
United States |
Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention |
4R37CA235602-06 |
|
Brandy Heckman-Stoddard, Ph.D., M.P.H. |
Torres, Keila Enitt |
University Of Tx Md Anderson Can Ctr
United States |
Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs |
1R01CA285980-01 |
|
Richard Mazurchuk, Ph.D. |
Trimble, Cornelia L |
Johns Hopkins University
United States |
Immunomodulatory effects of topical artesunate on cervical intraepithelial neoplasia 2/3. |
5R21CA263256-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H. |
Tussing-Humphreys, Lisa |
University Of Illinois At Chicago
United States |
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity |
3R01CA257807-04S1 |
|
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
Ulrich, Cornelia M |
University Of Utah
United States |
Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link |
5R01CA254108-04 |
|
Asad Umar, D.V.M., Ph.D. |
V, DHODAPKAR, MADHAV |
EMORY UNIVERSITY
United States |
Targeting microbial triggers of gammopathy for immunoprevention |
1UG3CA290302-01 |
|
|
Valdez, Erin G |
Stanford University
United States |
Circadian regulation of cancer therapy-associated neuroinflammation |
5R21CA267135-02 |
|
Marge Good, RN, M.P.H., OCN |
Valdimarsdottir, Heiddis |
Icahn School Of Medicine At Mount Sinai
United States |
Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation |
5R01CA260961-03 |
PAR-21-035 (R01 Clinical Trial Required) |
Marge Good, RN, M.P.H., OCN |